probability & profitability...and then some!

Given the current market cap of Prima Biomed:


PROBABILITY = 50%
CVac is a 50/50 to go to market (once funding is confirmed, which seems all but a done deal according to Martin Rogers). This 50/50 is based on trials and research to-date and also the non-toxic nature which makes it appealing even if success rate is not so great in Phase 3 trials. Although it's current trial results are better than Provenge and a few othrs. CVac could still see light without FDA approval if it failed Phase 3, however the market would not be as big.


PROFITABILITY = 1600% MINIMUM upside, 90% maximum downside.
Conservative workings based on DNDN and only on Ovarian cancer not the other potential cancers Cvac might work on that express Mucin-1.


Note: This profitability upside I have above is off CVac alone on Ovarian cancer. If CVac works in cancers that express Mucin-1 (breast, prostate, colon and lung) it is a multiplier (add a minimum $2 to the share price for each). It theoretically should work in other cancers and worked in renal cancer for a patient in early trials, however as previously mentioned the company chose to focus on Ovarian cancer as there were no other players or forms of treatment in that space. A smart strategic move by Prima!

Everyone is comparing PRR to DNDN, however DNDN is a one trick pony on one type of cancer (prostate) and has bigger side effects. Cvac may work in multiple cancers as is seen with the company pursuing an interest in breast cancer now too. Lead times on these trials will be short and go straight to end stage (phase 3) meaning CVac could be used in other cancers within 2 years of success with Ovarian cancer.

OTHER PRODUCTS:
Cripto-1 antibody could be bigger than CVac and the HPV vaccine would do extremely well too. This COULD mean an upside of well over 3000%, even 10000%+ upside.
It sounds silly, but this is a possible reality here.

Phase 3 results for CVac are pivotable for Prima's future, strong positive results will make it a major player in the biotech space.


A NEW ERA:
We are entering the biotech era...make no mistake about it.

All those people wishing they got onto the dot.com boom, this is your chance now! Don't be a spectator, get on board!!
The returns on some of these stocks will be unbelievable, not to mention you will be a part of something both positive and exciting!

Biotech won't be a bubble as it meets our most primal need to survive and live a quality life. As a result nothing can stop biotech advancing longterm.
Whether you're rich, poor, old, young, black, white, asian, girl or boy...everyone wants to live a long and happy life!!
Biotech will give everyone this opportunity one day, this day is fast approaching. You can help make this happen by supporting biotech by becoming a shareholder and recommending it to others.

For the record I have a friend going to America for treatment on Ovarian cancer with CVac. I hope for her sake more than mine that CVac works.

As always do your own research, but I'm in Prima Biomed for the long haul.